Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection

NCT04438694 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04438694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04438694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection
Lead sponsor
Cairo University
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 1, 2020
Completion date
December 31, 2021
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19